Cushing's disease arising from a clinically nonfunctioning pituitary adenoma

Endocrine Pathology

Volumn 17, Issue 2, 2006, Pages 191-199

  Salgado, Luiz Roberto ^a,c   Machado, Márcio Carlos ^a   Cukiert, Arthur ^a   Liberman, Bernardo ^a   Kanamura, Cristina Takami ^b   Alves, Venancio Avancini Ferreira ^b  

^a HOSPITAL BRIGADEIRO   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c NONE   (Brazil)

Author keywords

c erb B 2; Cushing's disease; Cushing's syndrome; Ki 67 antigen (Ki 67); Nonfunctioning pituitary adenoma; p53 protein (p53)

Indexed keywords

BROMOCRIPTINE; CORTICOTROPIN; DESMOPRESSIN; DEXAMETHASONE; EPIDERMAL GROWTH FACTOR RECEPTOR 2; HYDROCORTISONE; KETOCONAZOLE; KI 67 ANTIGEN; LEVOTHYROXINE; PROTEIN P53; THYROXINE;

ACTH SECRETING ADENOMA; ADULT; AMENORRHEA; ARTICLE; BIOPSY; CASE REPORT; CD4+ T LYMPHOCYTE; CUSHING DISEASE; DIAGNOSTIC PROCEDURE; FEMALE; GALACTORRHEA; GROWTH; HISTOPATHOLOGY; HORMONE RELEASE; HUMAN; HUMAN TISSUE; HYDROCORTISONE BLOOD LEVEL; HYDROCORTISONE URINE LEVEL; HYPERPROLACTINEMIA; HYPOPHYSIS ADENOMA; HYPOPHYSIS TUMOR; HYPOTHYROIDISM; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LABORATORY TEST; PRIORITY JOURNAL; RADIOSURGERY; VISUAL IMPAIRMENT;

ADENOMA; AMENORRHEA; CUSHING SYNDROME; FEMALE; GALACTORRHEA; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; PITUITARY ACTH HYPERSECRETION; PITUITARY NEOPLASMS;

EID: 33845708045     PISSN: 10463976     EISSN: None     Source Type: Journal    
DOI: 10.1385/EP:17:2:191     Document Type: Article

References (23)

1. Horvath E, Kovacs K. The adenohypophysis functional. Endocrine pathology. Malden, MA: Blackwell Scientific Publications, Inc., 1991.
2. Lloyd RV, Scheithauer BW, Kovacs K, Roche PC. The immunophenotype of pituitary adenomas. Endocr Pathol 7:145-150, 1996.
3. Katznelson L, Alexander JM, Klibanski A. Clinically non-functioning pituitary adenomas. J Clin Endocrinol Metab 76:1089-1094, 1993.
4. Gil-del-Alamo P, Pettersson KS, Saccomanno K, Spada A, Faglia G, Beck-Peccoz P. Abnormal response of luteinizing hormone beta subunit to thyrotrophin-releasing hormone in patients with non-functioning pituitary adenoma. Clin Endocrinol (Oxf) 41:661-666, 1994.
5. Kontogeorgos G. Molecular cytogenetics of pituitary adenomas, assessed by FISH technique. Front Horm Res 32:205-216, 2004.
6. Oppenheim DS, Klibanski A. Medical therapy of glycoprotein hormone-secreting pituitary tumors. Endocrinol Metab Clin North Am 18:339-353, 1989.
7. Tan EU, Ho MSJ, Rajasoorya CR. Metamorphosis of a non-functioning pituitary adenoma to Cushing's disease. Pituitary 3:117-122, 2000.
8. Baldweg SE, Pollock JR, Powell M, Ahlquist J. A spectrum of behavior in silent corticotroph pituitary adenomas. Br J Neurosurg 19:38-42, 2005.
9. Gogel EL, Salber PR, Tyrrel JB, Rosemblum ML, Findling J. Cushing's disease in a patient with a non-functioning pituitary tumor. Arch Intern Med 143:1040-1042, 1983.
10. Vaunghan NJA, Laroche CM, Goodman I, Davies MJ, Jenkins JS. Pituitary Cushing's disease arising from a previously non-functional corticotrophic chromophobe adenoma. Clin Endocrinol 22:147-153, 1985.
11. Bonner RA, Mukai K, Oppeinheimer JH. Two unusual variants of Nelson's syndrome. J Clin Endocrinol Metab 49:23-29, 1979.
12. Cooper ME, Murray RML, Kalnins R, Woodward J, Jerums G. The development of Cushing's syndrome from a previously silent pituitary tumor. Aust N Z Méd 17:249-251, 1987.
13. Gheri RG, Boddi W, Ammannati F, et al. Two-step development of a pituitary adenoma from hyperprolactinaemic syndrome to Cushing's disease. J Endocrinol Invest 20:240-244, 1997.
14. Kojima Y, Suzuki S, Yamamura K, Ohhashi G, Yamamura I. Comparison of ACTH secretion in Cushing's adenoma and clinically silent corticotroph adenoma by cell immunoblot assay. Endocrine J 49:285-292, 2002.
15. Ohta S, Nishizawa S, Oki Y, Yokoyama T, Namba H. Significance of absence prohormone convertase 1/3 in inducing clinically silent corticotroph pituitary adenoma of subtype I - immunohistochemical study. Pituitary 5:221-223, 2002.
16. Matsuno A, Okazaki R, Oki Y, Nagashima T. Secretion of high-molecular adrenocorticotropic hormone from a pituitary adenoma in a patient without Cushing stigmata. J Neurosurg 101:874-877, 2004.
17. Thapar K, Kovacs K, Scheithauer BW, et al. Proliferative activity and invasiveness among pituitary adenomas and carcinomas: an analysis using the MIB-1 antibody. Neurosurgery 38:99-106, 1996.
18. De Lellis RA, Lloyd RV, Heitz PU, Eng C, eds. Pathology and genetics of tumors of endocrine organs. Lyon, France: World Health Organization, IARC, 2004.
19. Katznelson L, Bogan JS, Trob JR, et al. Biochemical assessment of Cushing's disease in patients with corticotroph macroadenomas. J Clin Endocrinol Metab 83:1619-1623, 1998.
20. Thapar K, Scheithauer BW, Kovacs K, Pernicone PJ, Laws ER Jr. p53 expression in pituitary adenomas and carcinomas: correlation with invasiveness and tumor growth fractions. Neurosurgery 38:765-770, 1996.
21. Buckley N, Bates AS, Broome JC, et al. p53 Protein accumulates in Cushings adenomas and invasive non-functional adenomas. J Clin Endocrinol Metab 79:1513-1516, 1994.
22. Ezzat S, Zheng L, Smith HS, Asa SL. The c-erb-B-2/new proto-oncogene in pituitary tumors. Clin Endocrinol (Oxf ) 46:599-606, 1997.
23. Saeger W, Lübke D. Pituitary carcinomas. Endocr Path 1:21-35, 1996.